Non-Laboratory Pathway for Primary Health Centres (21 GBD Regions)
Non-Laboratory Engine: This algorithm estimates 10-year fatal and non-fatal cardiovascular risk using pure anthropometric and clinical data. It is specifically validated for use when serum lipid profiles are unavailable.
1. Epidemiology & Demographics
2. Anthropometrics & Vitals
3. Clinical History
Patient Synthesis
-
WHO HEARTS 10-Year CVD Risk
-%
-
Clinical Management Pathway
Academic Pearls & Clinical Pathophysiology
1. Mnemonic: The WHO "HEARTS" Package
The WHO HEARTS acronym defines the core pillars of cardiovascular disease management in primary care:
2. Pathophysiology: Why Use BMI Instead of Lipids?
In resource-limited settings (like Indian Primary Health Centres), waiting for fasting lipid profiles creates severe clinical inertia. BMI acts as a powerful non-laboratory surrogate for metabolic dyslipidaemia and insulin resistance. Central adiposity (captured by BMI) directly correlates with increased free fatty acid flux to the liver, driving up VLDL and LDL production while suppressing HDL. The WHO validated that substituting BMI for Total Cholesterol maintains robust predictive accuracy for 10-year outcomes.
3. The South Asian Multiplier
Epidemiological Context: The algorithm applies a 1.15x risk scalar for patients in the South Asian GBD region. South Asians exhibit the "Thin-Fat Phenotype"—a profound propensity to store visceral (omental) fat and ectopic liver fat at much lower BMIs compared to Caucasians. This drives early-onset endothelial dysfunction and an accelerated, highly inflammatory atherosclerotic plaque burden.
4. Illness Script: Laboratory vs. Non-Laboratory Risk Stratification
Algorithm Paradigm
Key Drivers
Ideal Clinical Setting
WHO HEARTS (Non-Lab)
Age, SBP, Smoking, Diabetes, BMI
Rural camps, Primary Health Centres (PHCs), resource-limited settings where immediate triage is required.
ASCVD PCE / QRISK3 (Lab)
Age, SBP, Smoking, Diabetes, Total Chol, HDL, LDL
Tertiary care, internal medicine outpatients. Higher accuracy for borderline statin initiation decisions.
5. Clinical Pitfall: Secondary Prevention Bypass
Critical Safety Alert: Never use ANY 10-year risk estimator (including WHO HEARTS) for a patient who already has established cardiovascular disease (prior MI, Stroke, Stent, CABG). These patients are automatically classified as highest risk and require immediate, high-intensity secondary prevention. This tool is strictly for Primary Prevention.
World Health Organization. HEARTS technical package for cardiovascular disease management in primary health care: risk based CVD management. Geneva: World Health Organization; 2020.
Kaptoge S, et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7(10):e1332-e1345.
How to Cite This Tool
AMA Style:
Umakanth S. WHO HEARTS CVD Risk Predictor. MEDiscuss. Published 2026. Accessed .
Vancouver Style:
Umakanth S. WHO HEARTS CVD Risk Predictor [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:
